Live
- MyVoice: Views of our readers 19th April 2024
- Peddireddi touched my feet for DCC post, recalls Kiran
- All politicos must commit to free press
- iPhone 17 Plus Rumors: Potential Smaller Screen Size for the 2025 iPhone
- Risk of Middle East escalation
- 50 families quit YSRCP, join TDP
- Nara Bhuvaneshwari to File Nomination Papers on Behalf of TDP Chief Chandrababu in Kuppam
- Tamil Nadu BJP Chief Announces End Of Dravidian Politics, Foresees BJP Surge
- YS Jagan's Memanta Siddham Bus Yatra begins in Rajapuram, to enter Kakinada by evening
- Not just promises, look for capacity to deliver them
Novavax Covid-19 vaccine Adjuvanted gets expanded approval in US
Highlights
Novavax says the US Food and Drug Administration (FDA) has granted expanded emergency use authorisation for its Covid-19 vaccine Adjuvanted for adolescents aged between 12-17 years.
Novavax says the US Food and Drug Administration (FDA) has granted expanded emergency use authorisation for its Covid-19 vaccine Adjuvanted for adolescents aged between 12-17 years.
The US company said the vaccine was the first protein-based Covid-19 jab authorised in the US, dpa news agency reported.
Doses of the Adjuvanted are available for use in adolescents upon the Centers for Disease Control and Prevention's (CDC) recommendation, the company noted.
In July 2022, the FDA had granted emergency use authorisation for a two-dose primary series in adults aged 18 years and older, followed by a recommendation from the CDC Advisory Committee on Immunisation Practices, and endorsement from the CDC.
Next Story
ADVERTISEMENT
